BMJ  2005;331:713 (1 October), doi:10.1136/bmj.331.7519.713

News

FDA chief resigns without warning

New York

The first 150 words of the full text of this article appear below.

After only two months as commissioner, but 30 years at the organisation, Lester Crawford, head of the Food and Drug Administration, abruptly resigned last Friday. He sent an email message to FDA staff members saying, "It is time, at the age of 67, to step aside."

President Bush immediately named Andrew von Eschenbach, director of the National Cancer Institute, as temporary commissioner. Dr von Eschenbach said he would continue to hold both jobs.

The New York Times this week reported an anonymous government official as claiming that Dr Crawford's resignation was related to the fact that he had not fully disclosed financial information during Senate hearings on his confirmation (Sep 24; Sect A: 1). Dr Crawford's wife, Catherine W Crawford, subsequently denied this on his behalf (New York Times, Sep 27; Sect A: 21).

Dr Crawford's resignation comes after a difficult year for the FDA, in which it . . . [Full text of this article]

-->
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Former FDA commissioner is fined $90 000 for failing to disclose conflicts of interest

Janice Hopkins Tanne
BMJ 2007 334: 492. [Extract] [Full Text] [PDF]

FDA appointment is stalled as revelations emerge over Plan B

Janice Hopkins Tanne
BMJ 2006 333: 317. [Extract] [Full Text] [PDF]

Senators block Bush nominee to head FDA

Janice Tanne
BMJ 2006 332: 686. [Extract] [Full Text] [PDF]

FDA criticised for rejecting over the counter emergency contraception

Janice Hopkins Tanne
BMJ 2005 331: 1223. [Extract] [Full Text] [PDF]

Another FDA expert resigns over emergency contraception delay

Janice Hopkins Tanne
BMJ 2005 331: 861. [Extract] [Full Text] [PDF]

In brief
BMJ 2005 331: 796. [Extract] [Full Text] [PDF]

FDA ducks decision on emergency contraceptive

Janice Hopkins Tanne
BMJ 2005 331: 596. [Extract] [Full Text] [PDF]

In brief
BMJ 2005 331: 472. [Extract] [Full Text] [PDF]

WMA sets rules on how doctors handle industry sponsorship

Zosia Kmietowicz
BMJ 2004 329: 876. [Extract] [Full Text]

Merck withdraws arthritis drug worldwide

Debashis Singh
BMJ 2004 329: 816. [Extract] [Full Text] [PDF]

FDA panel urges "black box" warning for antidepressants

Jeanne Lenzer
BMJ 2004 329: 702. [Extract] [Full Text]

This article has been cited by other articles:

• Tanne, J. H. (2006). FDA appointment is stalled as revelations emerge over Plan B. BMJ 333: 317-317 [Full text]  

Online poll

Find out more here>> and here>>